Use of Healthcare Claims Data to Generate Real-World Evidence on Patients With Drug-Resistant Epilepsy: Practical Considerations for Research
**Objectives:** Regulatory bodies, health technology assessment agencies, payers, physicians, and other decision-makers increasingly recognize the importance of real-world evidence (RWE) to provide important and relevant insights on treatment patterns, burden/cost of illness, product safety, and lon...
Saved in:
Main Authors: | Nicole Stamas, Tom Vincent, Kathryn Evans, Qian Li, Vanessa Danielson, Reginald Lassagne, Ariel Berger |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2024-02-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/001c.91991 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug response is related to NR3C1 and FAAH polymorphism in Chinese pediatric epilepsy patients
by: Hongli Wang, et al.
Published: (2025-02-01) -
Use of Sildenafil in Pulmonary Arterial Hypertension: Findings from a U.S. Healthcare Claims Database
by: Ariel Berger, et al.
Published: (2014-02-01) -
Painful Todd’s: Post-ictal painful hemiparesis as an identifier of insular epilepsy
by: Julian Larkin, et al.
Published: (2025-03-01) -
Use of Open Claims vs Closed Claims in Health Outcomes Research
by: Onur Baser, et al.
Published: (2023-09-01) -
Fertigation Nutrient Sources and Application Considerations for Citrus
by: Brian Boman, et al.
Published: (2002-07-01)